2024 / 02

DOI: 10.47183/mes.2024.028

ORIGINAL RESEARCH

Changes in some immunological parameters after COVID-19: general trends and individual characteristics

Glazanova TV, Shilova ER, Efremova YS, Chubukina JB, Bessmeltsev SS
About authors

Russian Hematology and Transfusiology Research Institute of the Federal Medical Biological Agency, St. Petersburg, Russia

Correspondence should be addressed: Tatyana Valentinovna Glazanova
2-ya Sovetskaya, 16, St. Petersburg, 191023, Russia; ur.xednay@avonazalg-anaytat

About paper

Compliance with the ethical standards: the study was approved by the Ethics Committee of the Russian Hematology and Transfusiology Research Institute of the FMBA of Russia (Minutes #31 of July 20, 2023). All participants have voluntarily signed informed consent forms.

Received: 2024-04-02 Accepted: 2024-06-08 Published online: 2024-06-30
|
  1. Ivanova IA, Omelchenko ND, Filippenko AV, Trufanova AA, Noskov AK. Rol' kletochnogo zvena immuniteta v formirovanii immunnogo otveta pri koronavirusnyh infekcijah. Medicinskaja immunologija. 2021; 23 (6): 1229–38. DOI: 10.15789/1563-0625-ROT-2302. Russian.
  2. Semenova EV, Pavljuk VV, Uvarova MA, Ivanov AV. Osobennosti gumoral'nogo immuniteta posle perenesennogo COVID-19. Medicinskaja immunologija. 2022. 24 (2): 337–50. DOI: 10.15789/1563-0625-FOH-2452. Russian.
  3. Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021; 184 (4): 861–80. DOI: 10.1016/j.cell.2021.01.007.
  4. Mohn KG, Bredholt G, Zhou F, et al. Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. PloS ONE. 2022; 17 (2): e0261979. DOI: 10.1371/journal.pone.0261979.
  5. Asfandijarova NS, Filippov EV, Dashkevich OV, Jakubovskaja AG, Mosejchuk KA, Zhuravleva NS, i dr. Faktory riska razvitija postkovidnogo sindroma. Klinicist. 2022; 16 (4): 19–26. DOI: 10.17650/1818-8338-2022-16-4-K671. Russian.
  6. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27 (4): 601–15. DOI: 10.1038/s41591-021-01283-z.
  7. Su S, Zhao Y, Zeng N, Liu X, Zheng Y, Sun J, et al. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. Molecular Psychiatry. 2023; 28 (10): 4056–69. DOI: 10.1038/s41380-023-02171-3.
  8. Generalova LV, Grigoriev IV, Vasina DV, Tkachuk AP, Kruzhkova IS, Kolobukhina LV et al. Properties of RBD specific IgG from COVID-19 patients and Sputnik V vaccinated individuals. Bulletin of RSMU. 2022; 1: 14–22. DOI: 10.24075/brsmu.2022.005.
  9. Taraskina AE, Frolova EV, Shadrivova OV, Sekretareva OV, Vasileva NV. Rol' immunnogo gomeostaza u pacientov s novoj koronavirusnoj infekciej (COVID-19) v razvitii invazivnogo aspergilleza legkih. Zhurnal infektologii. 2023; 15 (2): 14–23. DOI: 10.22625/2072-6732-2023-15-2-14-23.
  10. Wu J, Tang L, Ma Y, Li Y, Zhang D, Li Q, et al. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae. mBio. 2021; 12 (5): e0159921. DOI: 10.1128/mBio.01599-21.
  11. Orologas-Stavrou N, Politou M, Rousakis P, Kostopoulos IV, Ntanasis-Stathopoulos I, Jahaj E, et al. Peripheral blood immune profiling of convalescent plasma donors reveals alterations in specific immune subpopulations even at 2 months post sars-cov-2 infection. Viruses. 2021; 13 (1): 26. DOI: 10.3390/v13010026.
  12. Asfandijarova NS, Rubcova MA. Mozhet li disfunkcija kletochnogo immuniteta rassmatrivat'sja kak priznak postkovidnogo sindroma? Rossijskij immunologicheskij zhurnal. 2023; 26 (2): 173–80. DOI: 10.46235/1028-7221-2067-MBD. Russian.
  13. Sizjakina LP, Skripkina NA, Antonova EA, Sizjakin DV. Dinamika kliniko-immunologicheskih pokazatelej u pacientov, perenesshih COVID-19 srednetjazhelogo techenija i poluchavshih terapiju s vkljucheniem ingibitora janus-kinaz. Immunologija. 2023; 44 (2): 191–201. DOI: 10.33029/0206-4952-2023-44-2-191-201. Russian.
  14. Ketlinskij SA., Kalinina NM. Immunologija dlja vracha. SPb.: Gippokrat, 1998; 156 s. Russian.
  15. Kazakov SP, Reshetnjak DV, Davydova NV, Efimushkina OA, Putkov SB. Analiz i sravnitel'naja ocenka jeffektivnosti gumoral'nogo immunnogo otveta posle vakcinacii «Sputnik V» s ispol'zovaniem razlichnyh naborov reagentov. Infekcija i immunitet. 2023; 13 (3): 469–80. DOI: 10.15789/2220-7619-VRK-197. Russian.
  16. Mather MW, Jardine L, Talks B, Gardner L, Haniffa M. Complexity of immune responses in COVID-19. Seminars in Immunology. 2021; 55: 101545. DOI: 10.1016/j.smim.2021.101545.
  17. Han JH, Womack KN, Tenforde MW, et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Other Respir Viruses. 2022; 16 (4): 680–9. DOI:10.1111/irv.12980.
  18. Battaglini D, Robba C, Fedele A, et al. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med. 2021; 8: 671714. DOI: 10.3389/fmed.2021.671714.
  19. Gracia-Ramos A, Martin-Nares E, Hernandez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021; 10: 3592. DOI: 10.3390/cells10123592.
  20. Woodruff M, Ramonell R, Haddad N, Anam F, Rudolph M, Walker T et al. Dysregulated naïve B cells and de novo autoreactivity in severe COVID-19. Nature. 2022; 611 (7934): 139–47. DOI: 10.1038/s41586-022-05273-0.
  21. Kovtun OP, Olenkova OM, Bejkin JaB. Immunnyj otvet pri novoj koronavirusnoj infekcii Covid-19 u detej i vzroslyh. Ural'skij medicinskij zhurnal. 2021; 20 (4): 12–17. DOI: 10.52420/2071-5943-2021-20-4-12-17. Russian.
  22. Zheng HY, Zhang M, Yang CX, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol. Immunol. 2020; 17(5): 541–43. DOI:10.1038/s41423-020-0401-3